Discover Screener Plans Log In Sign Up
ELV
Elevance Health Inc.
Summary
Business
Earnings Call
Valuation
Profitability
Financial Health
Intel
Yearly Return 10Y annualized return is average at 9.1% per year
Earnings Expectations ELV has met or exceeded earnings expectations in most recent quarters (9/10)
Positive Attractive Price-to-Earnings Ratio
Positive Low Price-to-Sales Ratio
Negative High Price-to-Free Cash Flow Ratio
Negative Moderate EV to EBITDA Ratio

Unlock Complete Analysis

Get access to all key takeaways, detailed financial metrics, and comprehensive stock analysis with our premium subscription.

Complete key takeaways analysis
Advanced financial metrics
Real-time insights & alerts
Start Your Premium Journey

Already have an account? Sign in

Overall, Elevance Health demonstrates a strong commitment to improving member care and expanding its market presence through innovative strategies. However, challenges such as membership declines and elevated cost trends in Medicaid raise concerns about stability and future growth. The company’s proactive approach in managing these challenges, alongside promising growth projections, positions it well for the future.

Analysis Date: January 23, 2025
Last Updated: May 29, 2025

+140%
+9.1% per year

Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.

Country US
Exchange NYSE
Industry Medical - Healthcare Plans
Sector Healthcare
Market Cap $88.05B
CEO Ms. Gail Koziara Boudreaux

Elevance Health Inc. is a company that helps people get the healthcare they need. They provide health insurance and other support services to individuals and families, making it easier for them to access doctors, medications, and mental health resources. Founded in 1944 and based in Indianapolis, Elevance Health aims to improve the health and well-being of about 118 million people by connecting them with the care and resources that can help them live healthier lives.

Streams of revenue

Health Benefits Segment: 58%
Carelon Services Segment: 42%

Geographic Distribution

United States: 97%
International: 3%

Estimations for reference only

Core Products

πŸ‘΅
Medicare Plans Senior health plans
πŸ˜ƒ
Dental & Vision Dental/vision plans
πŸ₯
Anthem Blue Cross Health insurance
🩺
Medicaid Services Low-income health aid
πŸ’Š
Pharmacy Benefits Drug coverage

Business Type

B2C Business to Consumer

Competitive Advantages

Unlock Competitive Advantages Analysis

Discover all competitive advantages and strategic moats that protect ELV's market position.

View Premium Analysis

Key Business Risks

Unlock Complete Risk Analysis

Get comprehensive insight into all key business risks that could impact ELV's performance.

Access Full Risk Analysis

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Graham Value Metrics

Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.

πŸ“Š

Unlock Graham value analysis

Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis

βœ“ Intrinsic value calculations
βœ“ Margin of safety analysis
βœ“ Complete Graham criteria checklist
βœ“ Value investing insights
Upgrade to Premium

ROE: 13.94006502379494

ROA: None

Gross Profit Margin: 62.59146807627618

Net Profit Margin: 3.231143924335423

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Scroll horizontally to see more

About Profitability Metrics

Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.

πŸ“Š

Unlock Profitability Metrics

Access detailed profitability metrics with visual gauges and benchmarks

  • β€’ Return on Equity (ROE) analysis
  • β€’ Return on Assets (ROA) insights
  • β€’ Gross & Net Profit Margins
  • β€’ Industry benchmark comparisons
Sign Up for Premium
πŸ’ͺ

Unlock profitability strengths

Access detailed analysis of profitability strengths and positive performance indicators

Upgrade to Premium
⚠️

Unlock profitability weaknesses

Access detailed analysis of profitability weaknesses and areas of concern

Upgrade to Premium

About Financial Health Metrics

Financial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.

🏦

Unlock Financial Health Metrics

Access detailed financial health metrics with visual gauges and risk assessments

  • β€’ Debt to Equity ratio analysis
  • β€’ Current ratio & liquidity insights
  • β€’ Financial risk assessments
  • β€’ Stability benchmarks
Sign Up for Premium
πŸ›‘οΈ

Unlock financial strengths

Access detailed analysis of financial health strengths and stability indicators

Upgrade to Premium
⚠️

Unlock financial weaknesses

Access detailed analysis of financial health weaknesses and risk factors

Upgrade to Premium

Meeting Expectations

9 /10

Higher values indicate better execution and credibility

Recent Results

πŸ”’

Unlock earnings history

View complete earnings history and detailed performance analysis

Upgrade to Premium

EPS

11.41
Estimated
11.97
Actual
+4.91%
Difference

Revenue

$46299785774
Estimated
$48891000000
Actual
+5.60%
Difference
πŸ’ͺ

Unlock strenghts analysis

Unlock complete business strengths analysis

Upgrade to Premium
⚠️

Unlock weaknesses analysis

Unlock complete business weaknesses analysis

Upgrade to Premium
πŸš€

Unlock opportunities analysis

Unlock complete future opportunities analysis

Upgrade to Premium
⚑

Unlock risk analysis

Unlock complete future risks analysis

Upgrade to Premium

Insider trading data shows purchase and sale activities by company executives and board members.

Insider Sentiment Analysis

Insider trading patterns can provide insights into how company executives and board members view the stock's future prospects.

πŸ”

Unlock Insider Analysis

Get complete insider sentiment analysis with detailed trading patterns, sentiment indicators, and trend insights

  • β€’ Insider buy/sell ratio analysis
  • β€’ Total bought vs sold volumes
  • β€’ Active insider tracking
  • β€’ Recent trend analysis
Sign Up for Premium

ELV Stock Analysis: Elevance Health Inc. Investment Guide

ELV (Elevance Health Inc.) is a Healthcare company listed on New York Stock Exchange. The stock has generated 9.1% annual returns with an overall investment score of None/100.

Overall, Elevance Health demonstrates a strong commitment to improving member care and expanding its market presence through innovative strategies. However, challenges such as membership declines and elevated cost trends in Medicaid raise concerns about stability and future growth. The company’s proactive approach in managing these challenges, alongside promising growth projections, positions it well for the future.

ELV Key Financial Metrics

ELV financial analysis includes comprehensive valuation ratios, profitability metrics, and financial health indicators. The company has a valuation score of 5.0/100 with financial health rated 8.4/100.

About Elevance Health Inc.

Elevance Health Inc. is a company that helps people get the healthcare they need. They provide health insurance and other support services to individuals and families, making it easier for them to access doctors, medications, and mental health resources. Founded in 1944 and based in Indianapolis, Elevance Health aims to improve the health and well-being of about 118 million people by connecting them with the care and resources that can help them live healthier lives.

ELV Investment Recommendation

Based on our comprehensive analysis of ELV, investors should consider the company's positive performance track record, earnings consistency (9/10 quarters beat expectations), and current valuation metrics when making investment decisions.

Healthcare Sector Analysis

ELV operates in the Medical - Healthcare Plans industry within the Healthcare sector. This analysis compares Elevance Health Inc. performance against industry and sector benchmarks to provide context for investment decisions.

Frequently Asked Questions about ELV Stock

Is ELV a good investment?

ELV (Elevance Health Inc.) has generated 9.1% annual returns with an overall score of None/100. Overall, Elevance Health demonstrates a strong commitment to improving member care and expanding its market presence through innovative strategies. However, challenges such as membership declines and elevated cost trends in … Investors should consider their risk tolerance and investment goals when evaluating ELV.

What is ELV P/E ratio and valuation?

ELV valuation metrics including P/E ratio, price-to-book ratio, and price-to-sales ratio are analyzed on this page with comparisons to Medical - Healthcare Plans industry and Healthcare sector benchmarks. The company currently has a valuation score of 5.0/100.

Should I buy ELV stock now?

The decision to buy ELV stock should be based on comprehensive analysis of financial metrics, market conditions, and individual investment goals. Our analysis provides , financial health score of 8.4/100, and detailed performance metrics to help inform your investment decision.

What are ELV financial health indicators?

ELV financial health analysis includes liquidity ratios, debt levels, cash flow metrics, and profitability indicators. The company has a financial health score of 8.4/100 based on comprehensive analysis of balance sheet strength and operational efficiency.

How does ELV compare to competitors?

ELV performance is benchmarked against Medical - Healthcare Plans industry peers and Healthcare sector averages. Our analysis includes comparative valuation ratios, profitability metrics, and growth indicators to provide context for Elevance Health Inc.'s market position.

What are ELV historical returns?

ELV has generated 9.1% annual returns over the 10Y. Historical performance analysis includes price appreciation, dividend yields, and total shareholder returns compared to market benchmarks.

ELV Key Investment Metrics Summary

  • Annual Return: 9.1%
  • Valuation Score: 5.0/100
  • Financial Health Score: 8.4/100
  • Growth Score: -2.408845334086461/100
  • Earnings Beat Rate: 9/10 quarters
  • Sector: Healthcare
  • Industry: Medical - Healthcare Plans
  • Exchange: New York Stock Exchange
  • Market Cap: 88049566950

ELV Investment Thesis

Elevance Health Inc. (ELV) represents a moderate investment opportunity in the Healthcare sector. With an overall score of None/100, the company demonstrates areas for financial improvement.

Investment Strengths

  • Attractive Price-to-Earnings Ratio
  • Low Price-to-Sales Ratio
  • Strong Gross Profit Margin
  • Good Return on Equity
  • Solid Current and Quick Ratios
  • Strong Interest Coverage Ratio
  • Strong Member Retention
  • Innovative Care Models
  • Expansion of Carelon
  • Guidance for Membership Growth
  • Investments in Technology and Data
  • Commitment to Shareholder Returns

Investment Risks

  • High Price-to-Free Cash Flow Ratio
  • Moderate EV to EBITDA Ratio
  • Low Net Profit Margin
  • Low Operating Profit Margin
  • Moderate Debt Levels
  • Low Cash Ratio
  • Membership Decline
  • Elevated Cost Trends in Medicaid
  • Regulatory Uncertainties
  • Pricing Challenges
Home Screener Search Profile

During the beta period, we're currently displaying stocks from the S&P 500 index only. More stocks will be added soon.

Loading...